BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 30267473)

  • 21. Myosin 5a regulates tumor migration and epithelial-mesenchymal transition in esophageal squamous cell carcinoma: utility as a prognostic factor.
    Sato N; Fujishima F; Nakamura Y; Aoyama Y; Onodera Y; Ozawa Y; Ito K; Ishida H; Kamei T; Watanabe M; Sasano H
    Hum Pathol; 2018 Oct; 80():113-122. PubMed ID: 29898384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesenchymal Stromal Cells-Derived β2-Microglobulin Promotes Epithelial-Mesenchymal Transition of Esophageal Squamous Cell Carcinoma Cells.
    Wang J; Yang W; Wang T; Chen X; Wang J; Zhang X; Cai C; Zhong B; Wu J; Chen Z; Xiang AP; Huang W
    Sci Rep; 2018 Apr; 8(1):5422. PubMed ID: 29615660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bit1 knockdown contributes to growth suppression as well as the decreases of migration and invasion abilities in esophageal squamous cell carcinoma via suppressing FAK-paxillin pathway.
    Fan T; Chen J; Zhang L; Gao P; Hui Y; Xu P; Zhang X; Liu H
    Mol Cancer; 2016 Mar; 15():23. PubMed ID: 26956728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.
    Guo W; Liu S; Dong Z; Guo Y; Ding C; Shen S; Liang J; Shan B
    Clin Exp Metastasis; 2018 Feb; 35(1-2):53-68. PubMed ID: 29524086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HCRP1 inhibits cell proliferation and invasion and promotes chemosensitivity in esophageal squamous cell carcinoma.
    Wu Y; Yang Y; Xian YS
    Chem Biol Interact; 2019 Aug; 308():357-363. PubMed ID: 31152734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA‑675‑3p promotes esophageal squamous cell cancer cell migration and invasion.
    Xiao Q; Chen T; Wu Y; Wu W; Xu Y; Gong Z; Chen S
    Mol Med Rep; 2018 Oct; 18(4):3631-3640. PubMed ID: 30106155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional Role of a Novel Long Noncoding RNA
    Lin C; Zhang S; Wang Y; Wang Y; Nice E; Guo C; Zhang E; Yu L; Li M; Liu C; Hu L; Hao J; Qi W; Xu H
    Clin Cancer Res; 2018 Jan; 24(2):486-498. PubMed ID: 29101304
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of miR‑106b‑3p on cell proliferation and epithelial‑mesenchymal transition, and targeting of ZNRF3 in esophageal squamous cell carcinoma.
    Qiao G; Dai C; He Y; Shi J; Xu C
    Int J Mol Med; 2019 Apr; 43(4):1817-1829. PubMed ID: 30816445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of long non-coding RNA LOC101928477 correlates with tumor progression by regulating the epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Kong D; Long D; Liu B; Pei D; Cao N; Zhang G; Xia Z; Luo M
    Thorac Cancer; 2021 May; 12(9):1303-1311. PubMed ID: 33713583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RECQL4 regulates DNA damage response and redox homeostasis in esophageal cancer.
    Lyu G; Su P; Hao X; Chen S; Ren S; Zhao Z; Gong Y; Liu Q; Shao C
    Cancer Biol Med; 2021 Feb; 18(1):120-138. PubMed ID: 33628589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FGFR4 role in epithelial-mesenchymal transition and its therapeutic value in colorectal cancer.
    Peláez-García A; Barderas R; Torres S; Hernández-Varas P; Teixidó J; Bonilla F; de Herreros AG; Casal JI
    PLoS One; 2013; 8(5):e63695. PubMed ID: 23696849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma.
    Xu J; Zhu C; Yu Y; Wu W; Cao J; Li Z; Dai J; Wang C; Tang Y; Zhu Q; Wang J; Wen W; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; He Z; Pan X; Wei H; Zhu Y; He Y; Que J; Luo J; Chen L; Wang W
    EBioMedicine; 2019 Aug; 46():54-65. PubMed ID: 31324603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD276 promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma through the TGF-β/SMAD signaling.
    Zhang X; Xu C; Wang C; Pei Y; He M; Wan Z; Hou J; Wang L
    Clin Exp Metastasis; 2024 Apr; 41(2):81-90. PubMed ID: 38396262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNAJB6 Promotes Ferroptosis in Esophageal Squamous Cell Carcinoma.
    Jiang B; Zhao Y; Shi M; Song L; Wang Q; Qin Q; Song X; Wu S; Fang Z; Liu X
    Dig Dis Sci; 2020 Jul; 65(7):1999-2008. PubMed ID: 31701262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.
    Xu YF; Yang XQ; Lu XF; Guo S; Liu Y; Iqbal M; Ning SL; Yang H; Suo N; Chen YX
    Biochem Biophys Res Commun; 2014 Mar; 446(1):54-60. PubMed ID: 24565842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel ESCC-related gene ZNF750 as potential Prognostic biomarker and inhibits Epithelial-Mesenchymal Transition through directly depressing SNAI1 promoter in ESCC.
    Kong P; Xu E; Bi Y; Xu X; Liu X; Song B; Zhang L; Cheng C; Yan T; Qian Y; Yang J; Ma Y; Cui H; Zhai Y; Zou B; Liu X; Cheng Y; Guo S; Cheng X; Cui Y
    Theranostics; 2020; 10(4):1798-1813. PubMed ID: 32042337
    [No Abstract]   [Full Text] [Related]  

  • 37.
    Cho SH; Hong CS; Kim HN; Shin MH; Kim KR; Shim HJ; Hwang JE; Bae WK; Chung IJ
    Cancer Res Treat; 2017 Jul; 49(3):766-777. PubMed ID: 27857023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration.
    Xiao J; Yang W; Xu B; Zhu H; Zou J; Su C; Rong J; Wang T; Chen Z
    BMC Cancer; 2018 Oct; 18(1):976. PubMed ID: 30314454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA RP11-766N7.4 functions as a tumor suppressor by regulating epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Yao GL; Pan CF; Xu H; Wei K; Liu B; Zhai R; Chen YJ
    Biomed Pharmacother; 2017 Apr; 88():778-785. PubMed ID: 28157654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma.
    Zhu Y; Yuan T; Zhang Y; Shi J; Bai L; Duan X; Tong R; Zhong L
    Drug Des Devel Ther; 2019; 13():4321-4330. PubMed ID: 31908417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.